Advancing Care for Patients with Sjögren’s Related Dry Eye Disease

Advancing Care for Patients with Sjögren’s Related Dry Eye Disease

Our care and research: At Mark Hinds Optometrists and Ophthalmic Trials Australia, our team is committed to improving the lives of patients living with severe dry eye disease, ocular surface inflammation, and autoimmune-related eye disease through advanced clinical care, research, and innovation. One important area of focus is Sjögren’s related dry eye disease — a… Continue reading Advancing Care for Patients with Sjögren’s Related Dry Eye Disease

Corneal Neovascularisation and Scleral Contact Lenses: Why Oxygen Matters

Right eye of a patient showing significant corneal neovascularisation. Left eye of the same patient, without comparable corneal neovascularisation. Corneal neovascularisation refers to the growth of new blood vessels into the cornea. The cornea is normally clear and largely avascular, which is one of the reasons it can transmit light so effectively. When blood vessels… Continue reading Corneal Neovascularisation and Scleral Contact Lenses: Why Oxygen Matters

Scleral Contact Lens Fog

What happens over the day Immediately after insertion, the reservoir is mostly preservative-free filling solution mixed with some basal tears. During wear, several things occur: Does pH change? Probably yes, but direct human data measuring reservoir pH over time is limited. Mechanistically, the post-lens reservoir can drift more acidic because: So the concern is not… Continue reading Scleral Contact Lens Fog

Advancing Care for Patients with Ocular Graft-versus-Host Disease (oGVHD)

Our care and research: At Mark Hinds Optometrists and Ophthalmic Trials Australia (OTA), our team is committed to improving the lives of patients living with severe ocular surface disease through research, innovation, and compassionate clinical care. One area of increasing focus is ocular graft-versus-host disease (oGVHD) — a potentially debilitating complication that can occur following… Continue reading Advancing Care for Patients with Ocular Graft-versus-Host Disease (oGVHD)